Relx (NYSE:RENX) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report released on Thursday.

According to Zacks, “RELX NV provides professional information solutions primarily in North America and Europe. The company’s operating segments consists of Scientific, Technical & Medical; Risk & Business Information; Legal, and Exhibitions. Scientific, Technical & Medical segment provides information and tools to help customers improve scientific and healthcare outcomes. Risk & Business Information segment provides data and analytics which enable customers to evaluate and manage risk. Legal segment provides legal, regulatory, news, business information and analysis to legal, corporate, Government and academic customers. Exhibitions segment, through the subsidiary Reed Exhibitions, organizes market events relevant to industry needs. RELX NV, formerly known as Reed Elsevier NV, is based in Amsterdam, the Netherlands. “

Separately, UBS Group downgraded Relx from a “neutral” rating to a “sell” rating in a report on Thursday, June 14th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and two have assigned a buy rating to the company. The company currently has a consensus rating of “Hold” and an average price target of $23.00.

NYSE RENX opened at $21.83 on Thursday. Relx has a one year low of $20.06 and a one year high of $23.30. The stock has a market capitalization of $20.18 billion, a P/E ratio of 20.99, a price-to-earnings-growth ratio of 3.62 and a beta of 0.67. The company has a quick ratio of 0.37, a current ratio of 0.41 and a debt-to-equity ratio of 2.39.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in RENX. Wells Fargo & Company MN increased its holdings in Relx by 14.0% in the 1st quarter. Wells Fargo & Company MN now owns 298,522 shares of the technology company’s stock worth $6,207,000 after buying an additional 36,732 shares in the last quarter. CIBC Asset Management Inc grew its stake in shares of Relx by 13.1% during the 1st quarter. CIBC Asset Management Inc now owns 45,660 shares of the technology company’s stock valued at $949,000 after purchasing an additional 5,280 shares during the period. Massachusetts Financial Services Co. MA grew its stake in shares of Relx by 1.3% during the 1st quarter. Massachusetts Financial Services Co. MA now owns 193,368 shares of the technology company’s stock valued at $4,020,000 after purchasing an additional 2,511 shares during the period. Kayne Anderson Rudnick Investment Management LLC grew its stake in shares of Relx by 3.5% during the 1st quarter. Kayne Anderson Rudnick Investment Management LLC now owns 113,436 shares of the technology company’s stock valued at $2,358,000 after purchasing an additional 3,818 shares during the period. Finally, Natixis Advisors L.P. grew its stake in shares of Relx by 0.8% during the 1st quarter. Natixis Advisors L.P. now owns 409,300 shares of the technology company’s stock valued at $8,509,000 after purchasing an additional 3,361 shares during the period. Institutional investors own 1.28% of the company’s stock.

About Relx

RELX NV, through its interest in RELX Group plc, provides information and analytics for professional and business customers across industries worldwide. It operates through four segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment offers information and analytics to institutions and professionals.

Further Reading: Dividend Stocks – Are They Right For You?

Get a free copy of the Zacks research report on Relx (RENX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.